Abstract:In randomized trials, appropriately adjusting for baseline variables and short-term outcomes can lead to increased precision and reduced sample size. We examine the impact of such adjustment in group sequential designs, i.e., designs with preplanned interim analyses where enrollment may be stopped early for efficacy or futility. We address the following questions: how much precision gain can be obtained by appropriately adjusting for baseline variables and a short-term outcome? How is this precision gain impacted by factors such as the proportion of pipeline participants (those who enrolled but haven't yet had their primary outcomes measured) and treatment effect heterogeneity? What is the resulting impact on power and average sample size in a group sequential design? We derive an asymptotic formula that decomposes the overall precision gain from adjusting for baseline variables and a short-term outcome into contributions from factors mentioned above, for efficient estimators in the model that only assumes randomization and independent censoring. We use our formula to approximate the precision gain from a targeted minimum loss-based estimator applied to data from a completed trial of a new surgical intervention for stroke. Our formula implies that (for an efficient estimator) adjusting for a prognostic baseline variable leads to at least as much asymptotic precision gain as adjusting for an equally prognostic short-term outcome. In many cases, such as our stroke trial application, the former leads to substantially greater precision gains than the latter. In our simulation study, we show how precision gains from adjustment can be converted into sample size reductions (even when there is no treatment effect).

Sample size planning for estimating the global win probability with precision and assurance

A Nonparametric Global Win Probability Approach to the Analysis and Sizing of Randomized Controlled Trials With Multiple Endpoints of Different Scales and Missing Data: Beyond O'Brien–Wei–Lachin

Sample size formula for general win ratio analysis

Revisiting sample size planning for receiver operating characteristic studies: A confidence interval approach with precision and assurance

Sample Size Calculation for Single-Arm OPC Trials with Multi Endpoints

A Sample Size Planning Approach That Considers Both Statistical Significance and Clinical Significance

Improving Precision through Adjustment for Prognostic Variables in Group Sequential Trial Designs: Impact of Baseline Variables, Short-Term Outcomes, and Treatment Effect Heterogeneity

Sample size for a non-inferiority clinical trial with time-to-event data in the presence of competing risks

Power and Sample Size for Dose-Finding Studies with Survival Endpoints under Model Uncertainty.

Sample size re-estimation in a superiority clinical trial using a hybrid classical and Bayesian procedure

Asymptotic Results on a Class of Adaptive Multi-Treatment Designs

A Practical Simulation Method to Calculate Sample Size of Group Sequential Trials for Time-to-Event Data under Exponential and Weibull Distribution

Robust statistical inference for the matched net benefit and the matched win ratio using prioritized composite endpoints

A robust approach to sample size calculation in cancer immunotherapy trials with delayed treatment effect

Sample size estimation for cancer randomized trials in the presence of heterogeneous populations

Efficient and flexible simulation-based sample size determination for clinical trials with multiple design parameters

Sample Size Estimation in the Sequential Parallel Comparison Design and the Two-way Enriched Design

Sample size estimation for survival analysis in single-arm trials

Conditional Power and Friends: The Why and How of (Un)planned, Unblinded Sample Size Recalculations in Confirmatory Trials

Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions

Power/sample size calculations for assessing correlates of risk in clinical efficacy trials